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Ciliary dysfunction in polycystic kidney disease: an emerging
model with polarizing potential
Robert J. Kolb and Surya M. Nauli
Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425,
Department of Pharmacology and Medicine, College of Pharmacy and Medicine, University of
Toledo, Toledo, OH, 43606
Abstract
The majority of different cell types in the human body have a cilium, a thin rod-like structure of
uniquely arranged microtubules that are encapsulated by the surface plasma membrane. The
cilium originates from a basal body, a mature centriole that has migrated and docked to the cell
surface. The non-motile cilia are microtubule-based organelles that are generally considered
sensory structures. The purpose of this review is to discuss the practicality of the ciliary
hypothesis as a unifying concept for polycystic kidney disease and to review current literature in
the field of cilium biology, as it relates to mechanosensation and planar cell polarity. The
polycystins and fibrocystin localization at the cilium and other subcellular localizations are
discussed, followed by a hypothetical model for the cilium’s role in mechanosensing, planar cell
polarity, and cystogenesis.
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2. INTRODUCTION
Polycystic Kidney Disease (PKD) is a group of renal cystic diseases in which many forms
are inherited in a Mendelian fashion. The autosomal dominant form of PKD is the most
common type, characterized by isolated, large symmetrical bi-lateral cysts. The mechanism
of cyst formation is still unknown; however, indirect evidence showing many PKD gene
products localize to the primary cilium led to a ciliary hypothesis for PKD (1). The primary
cilium found in many cell types (2) is considered to be a fluid-flow sensor for the epithelial
cells lining the nephron (3, 4). In essence, the ciliary hypothesis states that dysfunctions in
proteins localized to the primary cilium cause PKD.
The inference from many studies investigating the primary cilium in association with PKD
is that altered mechanosensation is a key etiological factor in the cellular pathogenesis of
PKD, i.e., ciliary dysfunction leads to cyst formation. While this hypothesis is undoubtedly
novel and intriguing, recent claims have further garnished this model by suggesting its
potential to provide a "unifying pathogenic concept" for PKD (5). A unifying pathogenic
concept should require the integration of many well-described cellular pathologies of PKD
into a single testable experiment with the end result demonstrating strong evidence for a
direct mechanistic link between cilium function and cyst formation.
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This reductionist-like approach and its conclusions based on a cellular organelle with
unknown functions in the human kidney is risky, because it fails to integrate the data from
other studies showing the other cellular localizations and functions for polycystins, protein
products of PKD genes (6–15), as well as other cystic disease proteins (16–26).
Furthermore, functional data for proteins in the ciliary plasma membrane is limited.
Balancing the published data on the pathogenic mechanisms for PKD is necessary to
understand this complex disease. The balance begins by placing a weighted importance on
these cellular organelles and subcellular structures to their contribution of cellular
phenotypes observed in PKD that are based on functional studies with experimental
reproducibility.
Dysfunction of the cilium and centrosome as a cause of renal cystic diseases is, so far, one
of "guilty by association.” The ciliary hypothesis was developed from observations that
most of the cystic disease proteins localize to the cilium. Localization does not directly
imply importance; otherwise, the endoplasmic reticulum and Golgi apparatus, which
certainly contain all of these proteins, should be equally as “guilty”. However, proteins
associated with the human cystic diseases of the kidney (such as fibrocystin,
nephronophthisis-1 to 5, polycystin-1 and -2) also localize to the lateral junctions with many
of these proteins having other subcellular localizations and function (6, 14, 27). Moreover,
proteins such as Kif3A/B, polaris, and cystin exclusively localize to the cilium-basal body-
centriole axis, and when mutated in mice cause PKD. These proteins are cilium maintenance
proteins, yet none have a known association with human disease (28–32).
A notable exception is the BBS proteins that localize only to the cilium-basal body-centriole
axis where mutations of this protein group have been associated with Bardet-Biedl
syndrome (33). Thus, the two major pieces of evidence implicating the primary cilium, i.e.
ciliary localization and assembly, are circumstantial, given that there are no ciliary length
defects in human cystic kidney disease. Furthermore, no human disease is associated with a
protein that localizes exclusively to the cilium. Until we observe such differences, we must
consider ciliary dysfunction in PKD as a contributing factor rather than a primary cause of
PKD. Weighing the importance of a particular cellular compartment or localization better
affords us the opportunity to design treatments that will likely have the most efficacies in
treating PKD. Thus, we aim to carefully review the data on the subcellular localization of
cystoproteins in renal tubular epithelial cells and the functional significance at these locales
in PKD.
Conversely, the functional roles of the primary cilium are thought to be important in many
cellular processes, with emerging data suggesting that cilium dysfunction as a primary cause
in cystic diseases. Moreover, the "ciliary hypothesis" can explain the extra-renal phenotypes
in many of these cases (34, 35). Despite this fact, researchers should not overextend
themselves by focusing primarily on the cilium. Rather, a continuous effort should be made
to integrate the cilium's role into basic cellular functions and then objectively assign the
contribution of this organelle to the disease processes of PKD while giving careful
consideration to the non-cilium localization and functions of the cystic proteins. Otherwise,
we will fail to see the forest because we are too focused on the trees.
3. INHERITED POLYCYSTIC KIDNEY DISEASES
PKD is a leading cause of end stage renal disease (ESRD). Most forms of PKD are
hereditary although it may be acquired in patients who have had acute renal failure and
subsequent dialysis (34, 36–39). Autosomal dominant polycystic kidney disease (ADPKD)
is a frequently-occurring genetic disease of the kidney affecting one in every 500 to 1,000
individuals. The principle genes mutated in ADPKD are PKD1 (Polycystic Kidney Disease
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1) and PKD2 (Polycystic Kidney Disease 2), genes that encode for polycystin-1 (40, 41) and
polycystin-2 (42), respectively. More than 85% of ADPKD cases occur as a result of
mutations in PKD1, and mutations in PKD2 account for only 10%.
Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1
(Polycystic Kidney and Hepatic Disease 1) resulting in either a severe form, caused by two
different truncating mutations, or a moderate form, due to missense mutations or a missense
and truncating mutation in the encoded protein fibrocystin (43–45). The prevalence of
ARPKD is one in 20,000 live births, characterized with renal failure and hepatic fibrosis as
the primary cause of death in those infants.
While large focal cysts arising from the rapidly dividing tubular epithelial cells are the
hallmark of ADPKD, elongated cysts due to collecting duct dilatations are the key feature of
ARPKD. An important difference between the two is that cysts become isolated in ADPKD
while in ARPKD the cysts remain in contact with their tubular origin (46). The mechanism
for cyst formation in PKD is unclear. If or how cyst formation is a direct result of cilium
dysfunction remains the pivotal question. Studies have shown that polycystin-1,
polycystin-2, and fibrocystin localize to the primary cilium. These three proteins appear to
be in the same complex (47, 48). Furthermore, these proteins have been proposed to have a
role in mediating flow dependent mechanosensation (47, 49–54), suggesting a common
pathway in cyst development.
While it appears that the ciliary hypothesis explains the major forms of PKD, it cannot
explain other forms of renal cystic diseases found in humans. For example, mutations in
MCKD2 result in medullary cystic kidney disease (MCKD); however, Tamm-Horsfall
protein, the MCKD2 gene product, does not localize to the cilium or connecting
substructures (55, 56). Other renal cystic diseases, such as Bardet-Biedl syndrome, have a
direct link with a protein that is localized to the centrosome or basal body of primary cilia
(57). Distinguishing between the cilium, basal body, and the centrosome is a very important
task on both a morphological and functional level. Thus, it is imperative for us to weigh in
the relevance of “cysto” proteins to their localizations at the cilium.
For a more detailed description of human cystic diseases, please see the reviews by Wilson
(46), Igarashi (58) and others. For more detailed information on animal models of PKD,
please refer to reviews by Guay-Woodford (59) and Torres (60).
4. LOCALIZATION OF POLYCYSTINS AND FIBROCYSTIN
4.1. Tissue distribution
Immunohistochemical detection of polycystin-1 in human renal tissue indicates polycystin-1
is expressed in most nephron segments, although the precise spatial pattern remains unclear
(7, 61–63). This may be due to variations in the temporal and spatial expression pattern for
polycystin-1 between species confounded by changing cellular localizations during
development (63, 64). This is further complicated by individual studies using different
antibodies to various regions of polycystin-1, introducing an uncertainty in the detection of
full-length polycystin-1, and detection of protein products from homologous genes.
Moreover, antigen detection in tissue is difficult, often masked from fixation and the
documented results regarding the degradation of polycystin-1 (63).
Developmental studies show polycystin-1 localizes to the distal portion of the uteric bud
(15) as well as the portion of the uteric bud deep within the nephrogenic zone (63).
However, murine polycystin-1 localization studies have also demonstrated low levels of
polycystin-1 at the uteric bud (64) along with no detectable PKD1 mRNA in the uteric bud
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of human embryos at 10 weeks, challenging the role of polycystin-1 in nephrogenic
induction (65). Maturing cortical tubules and collecting ducts also express polycystin-1 at
moderately high levels during embryonic development (7, 64, 66). Other localization studies
show evidence for polycystin-1 expression within the glomerulus (66); either at the
glomerular tuft or parietal cells of Bowman’s capsule (7, 67). Polycystin-1 expression has
also been documented in vascular endothelial cells and smooth muscle cells (68–70). In
general, polycystin-1 expression declines after birth and is present at low levels in adults
with expression confined to the cortical and medullary collecting duct. Polycystin-1
expression is high in fetal tissues with tubular expression much lower in the collecting duct
during adulthood (7, 61). This developmental expression pattern along the nephron has led
to the hypothesis that polycystin-1 is involved in tubular differentiation during
nephrogenesis and tubular maintenance in the adult kidney.
Initial distribution studies showed identical polycystin-1 and polycystin-2 expression
patterns in human kidney tissue sections (71). This result was in conflict with data that
suggested distinct polycystin-1 and polycystin-2 distribution patterns within the mouse
kidneys (72). Subsequent localization studies revealed a temporal expression pattern for
polycystin-1 and polycystin-2, thereby reconciling the apparent discrepancy (64). The
current literature suggests that polycystin-2 expression occurs later in development than
polycystin-1 and maintains a greater level of expression in the adult (73). Interestingly,
PKD2 transcript and protein is detectable in human embryos earlier than PKD1 (72, 73).
The temporal and spatial differences between these two proteins suggest that they each have
two different roles, one of dependence and another of independence. The dependent role
prompted the hypothesis that the proteins form a functional complex in vivo that serves as a
convenient explanation for the similar phenotypes in ADPKD. This is further supported by
the evidence of the two polycystins’ interaction at their cytosolic COOH termini (74, 75) to
form functional complex in vivo (8, 53).
The Pkhd1 transcript has a complex pattern of splice variants (76, 77), and fibrocystin itself
undergoes a complicated pattern of proteolytic processing (78, 79). Fibrocystin has been
shown to express in a tissue-specific manner, which varies with the stage of tissue
development and cellular differentiation (80, 81). During kidney development, fibrocystin is
expressed in ureteric bud branches (80–82). Fibrocystin is also expressed in cortical and
medullary collecting tubular epithelia (47, 80, 83) and thick ascending limbs of Henle (80,
81). Expressions of fibrocystin in other tissues, such as liver and pancreas, have also been
reported (80, 82). The significance of fibrocystin in the tissue distribution during
development remains to be elucidated; its subcellular localization and functional
contributions in PKD will be discussed in the next sections.
4.2. Subcellular distribution
In vivo immunofluorescence and electron microscopy studies revealed that polycystin-1
localizes to the plasma membrane and cytoplasm (7, 62, 84, 85). In cultured cells,
polycystin-1 localizes to numerous membrane and cytosolic compartments including apico-
basolateral plasma membranes (62, 86–90), cytosolic vesicles (91), and endoplasmic
reticulum (92) with cleavage products detected in the nucleus (49, 50). The trafficking of
polycystin-1 to the lateral membranes may be due, in part, to a dependence on tuberin (88,
93). Furthermore, polycystin-1 trafficking to the plasma membrane is dependent upon the
cytoskeleton as the COOH terminal-tail directly interacts with intermediate filaments (94).
Polycystin-1 also has the capacity to bind to the extracellular matrix components such as
collagen I, laminin, fibronectin, and integrin (85, 95, 96). The localization of polycystin-1 to
multiple subcellular localizations suggests that it has multiple functions ranging from flow
sensing to cellular adhesion and differentiation.
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Tissue distribution studies have revealed the developmental regulation pattern for
polycystin-1 during nephrogenesis, and cell culture studies seem to indicate a temporal and
spatial pattern for polycystin-1 dependent upon the differentiation status. Polycystin-1
localizes to the desmosomes at the lateral membranes soon after establishment of cell-cell
junctions (14, 91, 97). When cell polarity is achieved and cellular differentiation begins,
polycystin-1 appears to interact with the tight junctional proteins E-cadherin and the
catenins (98). Establishment of adhesion and cell polarity allows the cell to enter a more
differentiated state (G0) where polycystin-1 can reside on the primary cilium (52, 99).
Interestingly, these three sites are essential in mechanotransduction, and the unique structure
of polycystin-1 lends itself to carrying out the diverse mechanosensing abilities required at
multiple cellular sites. Thus, as polycystin-1 spatial expression in tissue is indicatives of its
role in tubular differentiation, one would predict that cellular differentiation also results in a
spatial distribution for polycystin-1 expression.
Polycystin-2 resides within the endoplasmic reticulum (9, 100), plasma membrane (101–
103), primary cilium (52, 99, 104), and mitotic spindles (105). The details of how
polycystin-2 traffics to the cilium are limited, but current data suggests that there is a
specific ciliary signal sequence, which allows polycystin-2 to exit the endoplasmic reticulum
and enter the ciliary plasma membrane (106, 107). Interestingly, the localization of the
polycystins appears to be partially dependent on one another. For instance, in cells where
polycystin-2 is absent, polycystin-1 localizes to the plasma membrane and the endoplasmic
reticulum (92). In cultured epithelial cells with mutation in PKD1, localization of
polycystin-2 to cilia is not that apparent (53, 54). In polycystin-1 null cells, however,
polycystin-2 can still travel to the cilium, indicating that its localization is independent of
polycystin-1 (106). Thus, polycystin-2 localization to cilia appears to partially depend on
polycystin-1. Furthermore, polycystin-2 trafficking to the cilium is thought to be
independent from its phosphorylation status in the endoplasmic reticulum, but requires the
presence of IFT88 (108, 109). The role polycystin-1 and polycystin-2 have on each other as
it relates to ciliary trafficking requires further investigation.
Immunohistohemical analysis demonstrates that fibrocystin, like other cysto proteins, is
localized in centrosomes, basal bodies or primary apical cilia in renal epithelial cells.
Fibrocystin is also found at other subcellular localizations, such as cytosol, basal lateral
membrane and nucleus (78–83, 110). Recent studies show that fibrocystin indirectly
interacts with polycystin-2 at the cilium (47, 48) (Figure 1). Furthermore, it has been shown
that this indirect interaction between fibrocystin with polycystin-2 is necessary in regulating
polycystin-2 channel activity (48). This suggests that a similar mechanism of cystogenesis
may exist between ARPKD and ADPKD. The subcellular localization of fibrocystin being
unaltered in Pkd1 cells (110) suggests that the localization of fibrocystin is independent of
polycystin-1. Wang et al. have also shown in stable Pkhd1 knockdown cells, both
polycystin-1 and -2 expressions and localizations are not altered (47).
5. PRIMARY CILIUM AND PKD
An increasingly greater link between the mammalian primary cilium and human diseases
has put this organelle at the center of attention for many cell biologists. However, an absent
mechanistic link between cilium and cyst formation has made the functional significance of
this organelle elusive. The primary cilium is potentially a flow sensor for the luminal fluid
of the nephron, where cilium bending results in increasing cytosolic calcium. This paradigm
was established mainly from in vitro studies where cultured kidney cells were challenged
with a fluid-flow shear stress that bent the cilium, thereby activating intracellular calcium
stores and a subsequent rise in free intracellular calcium concentration (52, 111). Subsequent
studies then demonstrated that polycystins localize to the primary cilium of renal tubular
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epithelial cells, and when absent from the cilium or if inactivated, the fluid shear-induced
calcium response was abolished (52–54). However, the reproduction of these results using
an in vivo model has not been forthcoming. Ex vivo experiments using isolated gastrulation
stage node and perfused tubules have produced results confirming a mechanosensory
function for the primary cilium (51, 112). Future studies are still necessary to confirm that
the ciliary polycystins mediate the fluid-flow response in human adult nephron segments.
The cilium’s involvement in a broad range of cellular events such as cell cycle (3, 113) and
cell polarity (114, 115), along with differentiation and establishment of planar cell polarity
has made the task of determining its primary function in vivo difficult to establish (79, 116).
How these functions are interconnected, if indeed they are, is an important question, as it
may lead to insights into the pathogenesis of PKD. Furthermore, the quantitative properties
of cilium sensitivity to shear stress will afford researchers the opportunity to relate cilium
mechanosensory function to the luminal fluid-flow properties allowing for more accurate
predictions about cilium involvement in the mature nephron (117). Two possibilities are that
either the primary cilium is a low flow sensor that functions primarily during development
to facilitate planar cell polarity for establishing luminal diameter, or the primary cilium may
act as a maintenance sensor that allows the tubular cells to dedifferentiate and elongate
along the tubule when the nephron has been challenged with an insult. Thus, one possible
scenario is that during PKD development, the nephron is unable to repair itself correctly,
because the maintenance signaling from the cilium is absent or altered, forcing the tubular
cells into an unregulated repair mechanism.
5.1. Biology of a primary cilium
The primary cilium is a membrane-covered tubular-shaped extension filled with a highly
organized array of microtubules. The ciliary microtubules elongate from the preexisting
ones, which originated and grew from a basal body, a mature centriole that has migrated
within the cytosol to the apical surface. The basal body is integrated into the cytoskeleton
through its projections of transitional fibers, basal foot processes, and bundles of thin
filaments connecting it to the other centriole. Together, the basal body and centriole form a
centrosome, which serve as the cell’s main microtubule organizing center (118, 119).
The mammalian cilium is a diverse structure with multiple known functions, yet the main
function for primary cilium of renal cells is still not well understood. The ultrastructure of
the mammalian cilium was once thought to accurately predict its motility, e.g., 9+2 cilia
were presumed to always be motile and 9+0 considered immotile. The consensus was that
the 9+0 arrangement in many mammalian cilia was indicative of an inability to beat, since
the inner doublet was important for the beating pattern exemplified by lung epithelial cilia.
This is now known to be incorrect, as evidenced by the 9+0 motile cilium found in nodal
cells (120, 121). Moreover, in the rabbit and mouse node, there are multiple cilium types
ranging from 9+0, 9+2 and the newly discovered 9+4 (122).
The general distribution of the 9+0 or non-motile cilium occurs in tubular-based tissues such
as the nephron, bile duct, vascular system and pancreas. The 9+0 cilium is likely to function
as a flow sensor to monitor shear stress across the cell’s surface and subsequently relaying
this information back to the cytosolic compartment. The flow sensing function appears
critical in cystic disease, but whether or not the cilium has an important role in the adult
animal remains to be seen. Furthermore, the flow sensing capacity of the primary cilium has
been largely demonstrated in cultured cells. More in vivo data is warranted to support ciliary
role as an actual flow sensor.
The motile cilium’s role in vivo is supported by strong data suggesting its primary function
is to facilitate fluid movement in such places as the lung. Interestingly, under certain
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pathological conditions, a 9+2 cilium has been detected along the mammalian nephron (123,
124). This observation is intriguing and may occur to facilitate fluid movement along the
nephron. In particular, it has been reported that primary cilium in the zebrafish nephron is
motile (125). Future research will likely investigate such observations more closely, since
current research indicates the 9+0 or 9+2 microtubule arrangement is not an absolute
indicator of cilium motility (3).
Interestingly, the cilium appears to be integrated into the cell’s cytoskeletal and integrin
signaling pathways; it forms an apparent communication system that begins at the ciliary
membrane, diverges through the cell via the centrosome and microtubule organizing center,
and ultimately ends at the basal cellular adhesion sites. The basics of this communication
system were established by experiments where each component was systematically
disrupted while using ciliary calcium flow response as the functional readout. Thus, when
actin, tubulin, microfilaments, or integrins are not fully functional, the cell is unable to
initiate a flow response (126).
For a more detailed description of cilia structure and function, please see the works by
Praetorius (4), Satir (127), and others (3, 128, 129).
5.2. Ciliary mechanosensation proteins
Polycystin-1 (52, 99), polycystin-2 (52, 99, 104), and fibrocystins (82) are localized to the
primary cilium in renal epithelial cells, and their contribution to mechanosensation is not
fully understood. In vitro perfusion data strongly suggests that the polycystins (51– 54), and
presumably fibrocystin (47), are involved in the ciliary mediated response to flow by
initiating intracellular calcium release. This flow response is a result of cilium activation,
apparently from a low fluid-shear that causes the cilium to bend, with subsequent activation
of the polycystins and other interacting proteins in this complex along with the downstream
signaling components. The rise in intracellular calcium is likely one of a multitude of flow-
induced ciliary responses that may or may not arise directly from the cilium. This is an area
of much needed investigation. For instance, polycystin-1 binds to various heterotrimeric G
proteins (130–133), and the signal transduction arising from their activation may contribute
to the overall cellular response to flow. The non-calcium mediated signaling pathways may
possibly bridge ciliary information to the polycystins at other subcellular localizations (134).
Polycystin-1, polycystin-2, fibrocystin, and possibly other cysto proteins such as Kif3a/b
(Figure 1), can form a multi-protein complex at the primary cilium with mechanosensing
functions in cultured kidney lines (47, 48). Interestingly, the recent finding that a fibrocystin
at the ciliary plasma membrane has a cleavage product released into the lumen indicates
multiple functions for fibrocystin. The authors of this study went on to speculate that the
cleavage product may function in a paracrine fashion, possibly maintaining cell polarity of
the downstream tubular epithelium (79). Moreover, it is possible that fibrocystin cleavage is
an extracellular signaling event in response to mechanosensation, similar to polycystin-1 in
response to mechanical stress (49, 50). If these three proteins are in a signaling complex, and
polycystin-1 and polycystin-2 mutants give rise to a similar phenotype with many large focal
cysts, then it is interesting as to why the fibrocystin mutant results in a phenotype of tubular
dilatation.
Fibrocystin has also been suggested to play important role in ciliary structure and
morphology. Although there is conflicting evidence on the role of fibrocystin in regulating
length of a cilium (47), a previous study shows that 90% of Pkhd1 knockdown cells fail to
generate cilia (135). Furthermore, a more recent study shows that the primary cilia in the
bile ducts of Pkhd1 mice are structurally shorter than those of wild-type animals (136).
Using PCK rat as an animal model of ARPKD, Masyuk et. al. show that cilia are shorter and
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dysmorphic (137). They further show that cholangiocytes treated with Pkhd1 siRNA and
lacking fibrocystin have shorter cilia. Further characterization of the PCK liver phenotype
confirmed these findings, demonstrating that cilia from PCK rats are significantly shorter
and malformed with bulbous extensions of the ciliary tip (138).
The Orpk murine model of ARPKD, which is genetically different from human ARPKD,
has a stunted cilium (112, 139). Siroky et al. show that cells from the murine model of
ARPKD have abnormal apical flow sensing (140). There is also evidence that fibrocystin
may play a role in regulating intracellular calcium through ciliary mechanosensing (47).
Another study suggests that fibrocystin interacts with calcium modulating cyclophilin ligand
(CAML), a protein involved in calcium signaling (83). Since CAML is a calcium signaling-
related protein, the authors suggest that fibrocystin may also contribute to the modulation of
intracellular calcium in a manner similar to polycystins.
Although there is sufficient evidence to demonstrate that polycystins and fibrocystin are
localized to cilium, there certainly are many more questions that we could not answer about
these mechanosensory proteins. For example, as mentioned earlier in the review, the
expression levels of polycystin-1 change substantially during development where
polycystin-1 levels actually decrease towards adulthood. This raises the question of how
important the role of polycystin-1 is at the cilium in the matured adult tissue. The most
recent data shows that inactivation of Pkd1 in mice before postnatal day 13 results in
severely cystic kidneys within 3 weeks, whereas inactivation at day 14 results in cysts after
5 months (141). This indicates that polycystin-1 functions are still important in adulthood,
albeit more critical during development.
Generally speaking, studying the detailed nature of polycystin/fibrocystin signaling at the
cilium is a daunting task especially when one considers the large size of the proteins and the
technical difficulties associated with large glycoproteins and/or multiple proteolytic
isoforms.
6. PLANAR CELL POLARITY
Kidney tubules are constructed from sheets of polarized epithelial cells in a single plane,
which form a lumen for the transport of urinary fluid. Tubular formation is thought to occur
by processes such as planar cell polarity (PCP) as most epithelial tissues develop in a
polarized fashion identifiable by the microvilli and cilia extending from the cell surface. The
processes behind lumen formation are unknown, but tubular elongation occurs by orienting
cell division in the proliferative phase of tubular development.
One mechanism likely to play an important role in tubular development is PCP, a set of
processes that govern the polarization of epithelial cells and allow for the transfer of such
information to the newly developing cells. PCP involves a complex set of genes to establish
a 3-dimensional orientation of organ development. PCP involvement in tubulogenesis
appears to utilize another complex network of genes referred to as Wnt signaling (142).
Polycystin-1 has been recently shown to interact with the morphogens of the Wnt pathway
(143); however, it is not clear if this is directly related to PCP.
Wnt signaling pathways are grouped as canonical or non-canonical (144). Canonical Wnt
utilizes Frizzled (Fz) and LDL-related protein (LRP) co-receptors. In general, Wnt binds to
Fz receptors, inducing phosphorylation of disheveled (DSH). DSH activation inhibits the
APC-Axin-glycogen synthase kinase-3, allowing β-catenin to escape proteasomal
degradation. β-catenin levels in the nucleus presumably increase thereby activating Tcf
family members and Wnt target genes. Cannonical Wnt pathway is a process that guides the
proliferation of renal epithelial cells and aids the formation of apical-basolateral polarity.
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Non-canonical Wnt signaling occurs without β-catenin involvement and appears to have
some overlap with PCP in that these processes are principally concerned with the
development of tissues along a particular axis other than the apical-basolateral axis. Defects
in the development of tissue polarity in nephrogenesis are now being considered an essential
part of the disease processes associated with PKD. Orientated cell division (Figure 2) is
necessary for the elongation of the developing nephron. Recent work by Fischer et.al.
demonstrates that abnormalities in the PCP process are present in PKD as indicated by
differences in the programmed patterns of cell division in renal tubules elongating in normal
and in PKD animal models (116). In these studies, the PCK rat was found to have mitotic
spindles orientated outside of the tubular axis. In this disease model, as with the human
disease, cysts arise in the later stages of the animal’s life, which allowed the researchers to
conclude that mitotic spindle misalignment is not a result of cyst formation, but a likely
contributing factor due to the aberrant function of fibrocystin.
As mentioned earlier in this review, fibrocystin is in a complex with polycystin-1 and -2 at
the cilium (47, 48), and polycystin-1 interacts with the morphogens of the Wnt pathway
(143). It is interesting to speculate that the flow sensing capabilities of the cilium allow the
cell to incorporate the multitude of cellular signaling pathways based on fluid-flow
stimulation to activate the appropriate cell signaling pathway necessary for cellular
differentiation. For instance, during development, urinary flow rate and directions would be
sensed by the deflecting cilium allowing the cell to utilize the appropriate Wnt signaling
pathway for tubular elongation and establishment of PCP pathways allowing for
maintenance in the tubular architecture. Disruption of this complex abrogates normal flow
sensing processes, which triggers unregulated Wnt signaling and PCP pathways, leading to
cell division out of the tubular axis and promoting cyst formation.
Polycystin-1 has been shown to undergo cleavage in conditions where there is no fluid-flow
stimulation. Under these static conditions, the COOH-tail translocates to the nucleus
activating STAT6/P100 dependent genes; while under flow conditions, polycystin-1 is
bound to STAT6/P100 effectively preventing nuclear translocation (50). The COOH-tail of
polycystin-1 also reportedly acts to stabilize β-catenin, a well-characterized readout for
canonical Wnt signaling (98, 143). These two pieces of data suggest that the polycystin-1
COOH-tail functions to stabilize proteins, which determine cell-fate specification. For
example, fluid-flow stimulation provides a signal to the cell, via polycystin-1 COOH-tail
stabilization, to modulate gene expression, which directs the cell towards a differentiated
state. It is therefore easy to envision how under diseased states, where polycystin-1 COOH-
tail is unable to function as a mediator of cellular differentiation by its inability to sequester
proteins involved in proliferation, both Wnt and PCP signaling pathways could be disturbed
to alter cellular proliferation and cellular dedifferentiation. Much work is still needed to
determine the details of how the polycystins and other ciliary proteins are involved in the
canonical and non-canonical Wnt pathways, and whether or not they play a significant role
the initial events of cyst formation.
Currently, the literature suggests that β-catenin plays a pivotal role in the aberrant signaling
processes of PKD. Experiments where β-catenin is constitutively activated in transgenic
mice result in PKD in each segment of the nephron (21). Whether or not this directly relates
to mechanosensation is not clear. However, in one study in which a cilia specific protein,
Kif3A, was genetically altered in the mouse resulted in increased β-catenin levels and
displayed the cystic phenotype (30). Such studies strongly suggest that the polycystin
signaling complex at the cilium is important in Wnt signaling and maintenance of normal
tubular architecture.
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The early stages of nephron development are the key period for understanding the
mechanisms behind the PKD disease process. This process may involve crucial events in
establishing cell polarity, differentiation and tubulogenesis that involves Wnt signaling and
PCP events. Because cyst development occurs late in human adult life and the molecular
events behind cyst formation are those most active in development, this suggests that the
developmental process remain active in adulthood (141). This further indicates that a
transformation from development into maintenance process may occur in adult life.
7. PERSPECTIVES
Understanding how developmental events become critical in the adult kidney in PKD
patients is an important concept requiring further investigation. For example, we need to
further understand why in adult PKD cyst, the subcellular localizations of epidermal growth
factor receptor (EGFR) and Na+/K+ ATPase pump are transformed into patterns seen in
developing kidneys (145–148). At present, the molecular components mediating this switch
are thought to reside at the primary cilium. The current view suggests that mechanosensation
is important in maintaining tubular architecture and provides the cell with the ability to use
fluid-flow stimulation as a means for monitoring tubular differentiation (Figure 2). The
cilium is a fascinating organelle, which appears to be tightly integrated into many different
cellular processes ranging from cell cycle to cellular differentiation. Using the polycystins
and other cysto proteins as a mechanosensing complex, the cilium can rapidly respond to
changes in urinary fluid-flow by activating specific signaling pathways unique to each of the
individual proteins of this complex. Understanding the specific events connected to each of
the mechanosensing protein’s components at the cilium will help researchers better
understand both the functions of the primary cilium and more importantly, the events which
trigger cyst formation in PKD.
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Figure 1.
Mechanosensory protein complex. Among other subcellular localizations, it is thought that
polycystin-1, polycystin-2 and fibrocystin form a mechanosensory complex protein in the
cilium to sense fluid-shear stress. Polycystin-1 and polycystin-2 interact with each other at
their COOH termini forming a polycystin complex. It is predicted that fibrocystin interacts
with this complex through polycystin-2 via Kif as a possible adaptor protein.
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Figure 2.
Hypothetical model of cystogenesis. The illustration depicts mechanosensory function of
renal tubular epithelial cilium. a. Each cilium plays an important role to transmit
extracellular information, such as urine flow, into the cell. This message may provide
critical signals to the cell regarding the direction of cell division along the tubule. b. Insults,
such as genetic disorder or random mutation, will result in abnormal ciliary function to sense
fluid movement. c. The functional abnormality in ciliary sensing may result in loss of planar
cell polarity. d. Direction of cell division becomes randomized, resulting in increasing
tubular diameter rather than tubular elongation. e. Budding of a cyst from the renal tubule
and abnormal localizations of epidermal growth factor receptor (EGFR) and Na+/K+ ATPase
pump are typical characteristics of the autosomal dominant polycystic kidney. f. The cyst is
eventually enlarged and isolated. Multiple cysts from the neighboring nephrons are
illustrated on the bottom left corner.
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